Amsterdam Health & Technology Center
The AVS @ AHTC is a top-notch working space consisting of 6 furnished offices and some flexdesks with many services provided. It is situated on the 5th floor of the D-tower. The target audience are health (tech) startups.
The AVS @AHTC is run by ahti, the Amsterdam health & technology institute, which sets out to improve the health of the city and her citizens. HealthInc is the new accelerator program of ahti together with Amsterdam UMC, location AMC. It offers an intensive full-time twelve-week program for early stage health and technology entrepreneurs.
At the heart of the Amsterdam Life Sciences District, in the southeast of Amsterdam, is the Amsterdam Health & Technology Center (AHTC). It is an entrepreneurial hub connecting start-up and scale-up companies in health, research, and technology, as well as accelerators and investors.
Amsterdam UMC, location AMC is one of the foremost medical research institutions in the Netherlands, as well as one of its largest hospitals. With its 30,000 m2, the AHTC/AMC location is one big health tech community. Here, leading medical research facilities and health-related companies form an ecosystem of support for innovation.
Caelus Health develops Microbiome Therapeutics that reduces the risk of developing diabetes. Luc Sterkman, CEO: “The University of Amsterdam – AMC in particular – created the first crucial data and patents, helping us to attract external funding. IXA managed the patent portfolio, established the first licensing contracts and also helped us to secure a proof-of-concept grant of 100,000 euros”.
Please contact us
Start-ups and spin-offs affiliated to the Amsterdam Venture Studios establish new partnerships, keep developing and adjusting their innovative products and continue to take the stage in events, despite the disruptive changes the COVID-19 pandemic made in the entrepreneurial ecosystem. Partnerships Establishing new partnerships is important for start-ups. Through partnerships, start-ups can develop their market strategy […]News
LUMICKS, a spin-off of Vrije Universiteit Amsterdam, is pleased to announce a collaboration agreement with clinical-stage biotech company Leucid Bio, which seeks to utilize LUMICKS’ z-Movi® Cell Avidity Analyzer (z-Movi) to accelerate entry of immunotherapeutic candidates into clinical trials. The goal of the partnership is to evaluate the efficacy of Leucid Bio’s next-generation chimeric antigen […]News
The Dutch government’s yearly national budget, the Miljoenennota, initiates a budget implementation cycle. This consists of various phases; spending, adjusting, auditing and reporting. During this cycle, the Dutch Ministry of Finance collects a multitude of reports and other information resources, originating from various government sources. The Ministry used to manually copy the data and use […]News